Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06618183 · ClinicalTrials.gov registry record
Drug Screening System Method Comparison
A clinical trial of Reagent Kits, Diagnostic, sponsored by Intelligent Bio Solutions.
- Recruiting
- Registry status
- 135
- Enrollment target
- 3
- Study locations
NCT06618183 is a study of Reagent Kits, Diagnostic that is actively recruiting participants, run by Intelligent Bio Solutions. The registered enrollment target is 135 participants. The trial reports 3 study locations across 2 states.
The verdict
NCT06618183, a study of Reagent Kits, Diagnostic, is actively recruiting participants, sponsored by Intelligent Bio Solutions.
- RECRUITING
- Registry status
- 135 participants
- Enrollment target
- 3
- Study locations
Study Summary
Prospective, open-label, single-dose, randomized, multi-site performance evaluation of the accuracy and usability Intelligent Fingerprinting Drug Screening System in the hands of intended users: "operators" and "donors."
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Fingerprint sweat drug screen
- DIAGNOSTIC_TEST Fingerprint sweat laboratory analysis
Study Locations (3)
New Jersey
- CenExel HRI - Berlin
- CenExel HRI - Marlton
Georgia
- CenExel iResearch - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2024-08-26 |
| Est. Completion | 2024-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06618183
The ClinicalTrials.gov registry entry for NCT06618183 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intelligent Bio Solutions, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Reagent Kits, Diagnostic appearing as the primary indexed condition, and to 2 interventions - of which Fingerprint sweat drug screen is the first listed.
NCT06618183 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, Georgia.
Frequently Asked Questions
What is clinical trial NCT06618183 about?
NCT06618183 is a clinical study titled "Drug Screening System Method Comparison". Prospective, open-label, single-dose, randomized, multi-site performance evaluation of the accuracy and usability Intelligent Fingerprinting Drug Screening System in the hands of intended users: "operators" and "donors."
What is the current status of trial NCT06618183?
This trial is currently recruiting. The enrollment target is 135 participants. The study started on 2024-08-26. Estimated completion is 2024-12-31.
What conditions does trial NCT06618183 study?
This clinical trial studies the following conditions: Reagent Kits, Diagnostic.
What interventions are being tested in trial NCT06618183?
The interventions under investigation include: Fingerprint sweat drug screen (DIAGNOSTIC_TEST), Fingerprint sweat laboratory analysis (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06618183?
This trial is sponsored by Intelligent Bio Solutions, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06618183 being conducted?
This trial has 3 study locations across Georgia, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.